Study details
Enrolling now
Cefixime Clinical Trial
University of Southern California
NCT IDNCT04958122ClinicalTrials.gov data as of Apr 2026
Phase
Phase 3
Target enrollment
400
Study length
about 6 years
Ages
18+
Locations
1 site in CA
About this study
Researchers are testing cefixime compared to benzathine penicillin G in treating syphilis. The trial will involve 400 adults with early syphilis from sites in the U.S. and Peru, who will receive either cefixime or benzathine penicillin G for 9 months.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Cefixime 400mg
- 2.Take benzathine penicillin
PhasePhase 3
DrugCefixime 400mg
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low10%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
cefixime, benzathine benzylpenicillin
Drug routes
oral (Oral Capsule)
Body systems
Immune, Infectious